CASI Pharmaceuticals, Inc. Appoints Alexander A. Zukiwski as Executive Vice President
December 10, 2021 at 04:02 pm EST
CASI Pharmaceuticals, Inc. announced on December 2, 2021, the Compensation Committee of the Board of Directors of recommended, and, on December 8, 2021, the Board approved, a title change for Alexander A. Zukiwski, MD, from Chief Medical Officer to Executive Vice President and Chief Medical Officer. In addition, the Board expanded certain of Dr. Zukiwskis responsibilities. In connection with these changes, Dr. Zukiwskis base salary was raised to USD 504,000. Dr. Zukiwski was also allowed a USD 1,500 per month car allowance. Both are retroactive to August 16, 2021. In addition, the Board approved and amendment to Dr. Zukiwskis change in control agreement te extend the severance payments from nine months to 12 months.